2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium

C52H83N6O7Pd- — CID 157081833

IUPAC2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium
SMILESCO.C[C@@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(N)cn4)CC[C@@H]32)C1.C[C@@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc([N+](=O)[O-])cn4)CC[C@@H]32)C1.[CH3-].[Pd]
InChIInChI=1S/C25H37N3O4.C25H39N3O2.CH4O.CH3.Pd/c1-23(30)10-11-24(2)16(12-23)4-5-18-19-6-7-21(25(19,3)9-8-20(18)24)22(29)15-27-14-17(13-26-27)28(31)32;1-23(30)10-11-24(2)16(12-23)4-5-18-19-6-7-21(25(19,3)9-8-20(18)24)22(29)15-28-14-17(26)13-27-28;1-2;;/h13-14,16,18-21,30H,4-12,15H2,1-3H3;13-14,16,18-21,30H,4-12,15,26H2,1-3H3;2H,1H3;1H3;/q;;;-1;/t2*16-,18+,19+,20+,21-,23-,24+,25+;;;/m11.../s1
InChIKeyWQXRSEYYRXQNHF-JWOHTTPTSA-N
MW1010.69 g/mol
LogP9.27
Rot. Bonds7

About 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium

2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium (PubChem CID 157081833) has the molecular formula C52H83N6O7Pd- and a molecular weight of 1010.69 g/mol. Its IUPAC name is 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium.

Molecular Properties

Compound Name2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium
PubChem CID157081833
Molecular FormulaC52H83N6O7Pd-
Molecular Weight1010.69 g/mol
Exact Mass1009.54
IUPAC Name2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium
SMILESCO.C[C@@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(N)cn4)CC[C@@H]32)C1.C[C@@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc([N+](=O)[O-])cn4)CC[C@@H]32)C1.[CH3-].[Pd]
InChIInChI=1S/C25H37N3O4.C25H39N3O2.CH4O.CH3.Pd/c1-23(30)10-11-24(2)16(12-23)4-5-18-19-6-7-21(25(19,3)9-8-20(18)24)22(29)15-27-14-17(13-26-27)28(31)32;1-23(30)10-11-24(2)16(12-23)4-5-18-19-6-7-21(25(19,3)9-8-20(18)24)22(29)15-28-14-17(26)13-27-28;1-2;;/h13-14,16,18-21,30H,4-12,15H2,1-3H3;13-14,16,18-21,30H,4-12,15,26H2,1-3H3;2H,1H3;1H3;/q;;;-1;/t2*16-,18+,19+,20+,21-,23-,24+,25+;;;/m11.../s1
InChIKeyWQXRSEYYRXQNHF-JWOHTTPTSA-N
XLogP9.27
TPSA199.63 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001010.69
LogP ≤ 59.27
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium?
The IUPAC name of 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium (CID 157081833) is 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium.
What is the SMILES notation for 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium?
The canonical SMILES for 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium is CO.C[C@@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(N)cn4)CC[C@@H]32)C1.C[C@@]1(O)CC[C@@]2(C)[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc([N+](=O)[O-])cn4)CC[C@@H]32)C1.[CH3-].[Pd].
What is the InChIKey of 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium?
The InChIKey is WQXRSEYYRXQNHF-JWOHTTPTSA-N. The full InChI is InChI=1S/C25H37N3O4.C25H39N3O2.CH4O.CH3.Pd/c1-23(30)10-11-24(2)16(12-23)4-5-18-19-6-7-21(25(19,3)9-8-20(18)24)22(29)15-27-14-17(13-26-27)28(31)32;1-23(30)10-11-24(2)16(12-23)4-5-18-19-6-7-21(25(19,3)9-8-20(18)24)22(29)15-28-14-17(26)13-27-28;1-2;;/h13-14,16,18-21,30H,4-12,15H2,1-3H3;13-14,16,18-21,30H,4-12,15,26H2,1-3H3;2H,1H3;1H3;/q;;;-1;/t2*16-,18+,19+,20+,21-,23-,24+,25+;;;/m11.../s1.
What are the key properties of 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium?
2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium has a molecular weight of 1010.69 g/mol, XLogP of 9.27, 7 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-aminopyrazol-1-yl)-1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone;carbanide;1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-(4-nitropyrazol-1-yl)ethanone;methanol;palladium is sourced from PubChem (CID 157081833), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).